Nutex Health Director Frank E. Jaumot Receives 603 Shares

What Happened
Frank E. Jaumot, a director of Nutex Health, converted 603 restricted stock units (RSUs) into 603 shares of common stock on July 31, 2026. The filing lists the transaction as a derivative conversion (transaction code M) at an effective price of $0.00, so the reported acquisition value is $0.

Key Details

• Transaction date: 2026-07-31; Filing date: 2026-08-03 (filed within the Form 4 two-business-day requirement).
• Transaction: Conversion/exercise of a derivative (code M) — 603 shares acquired at $0.00 each; total reported value $0.
• Shares owned after transaction: Not specified in the provided filing summary.
• Footnote: F1 — Restricted stock units convert into common stock on a one-for-one basis.
• No sale or disposition reported in this filing (no immediate cashless sale indicated).

Context
This was a non-cash conversion of RSUs into common stock (vesting/settlement), not an open-market buy or sale. Such conversions are typically a routine part of equity compensation and do not by themselves indicate an insider buying or selling shares for liquidity or market sentiment.